{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:28:21Z","timestamp":1787506101003,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1053\/j.ajkd.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:03:33Z","timestamp":1686261813000},"page":"581-596.e0","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fabry Disease Nephropathy: Histological Changes With Nonclassical Mutations and Genetic Variants of Unknown Significance"],"prefix":"10.1053","volume":"82","author":[{"given":"Marisa","family":"Santostefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cappuccilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Gibertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Fabbrizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Malvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Demetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Tringali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cenacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Galdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianandrea","family":"Pasquinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ymgme.2021.02.001","article-title":"Standardising clinical outcomes measures for adult clinical trials in Fabry disease: a global Delphi consensus","volume":"132","author":"Moreno-Martinez","year":"2021","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","article-title":"Manifestations of Fabry disease in placental tissue","volume":"29","author":"Vedder","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2023.03.015_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.ajkd.2007.12.032","article-title":"Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria","volume":"51","author":"T\u00f8ndel","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.ajkd.2020.05.005","article-title":"Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference","volume":"76","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2023.03.015_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182379","article-title":"Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: analysis of prognostic factors","volume":"12","author":"Arends","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2023.03.015_bib6","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","first-page":"203","article-title":"Renal manifestations of Fabry disease","author":"Sunder-Plassmann","year":"2006"},{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.2009.072116","article-title":"Screening for Fabry disease in high-risk populations: a systematic review","volume":"47","author":"Linthorst","year":"2010","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2215\/CJN.09480819","article-title":"The changing landscape of Fabry disease","volume":"15","author":"Svarstad","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.03.015_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"issue":"9","key":"10.1053\/j.ajkd.2023.03.015_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10157-021-02058-z","article-title":"Pathology and pathogenic pathways in Fabry nephropathy","volume":"25","author":"Feriozzi","year":"2021","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2023.03.015_bib11","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/ndt\/gfp528","article-title":"Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)","volume":"25","author":"Fogo","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2012030316","article-title":"Agalsidase benefits renal histology in young patients with Fabry disease","volume":"24","author":"T\u00f8ndel","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2023.03.015_bib13","author":"Sirrs"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ymgme.2014.01.014","article-title":"Outcomes of patients treated through the Canadian Fabry disease initiative","volume":"111","author":"Sirrs","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"10","key":"10.1053\/j.ajkd.2023.03.015_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2215\/CJN.02150212","article-title":"Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010","volume":"7","author":"T\u00f8ndel","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.03.015_bib17","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.3390\/ijms22094434","article-title":"Fabry disease and the heart: a comprehensive review","volume":"22","author":"Azevedo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.ajkd.2023.03.015_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1905184","article-title":"Trans-septal myocardial biopsy in hypertrophic cardiomyopathy using the Liwen procedure: an introduction of a novel technique","volume":"2021","author":"Han","year":"2021","journal-title":"J\u00a0Interv Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18038-x","article-title":"A\u00a0next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases","volume":"7","author":"Boemer","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2023.03.015_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ymgme.2008.03.017","article-title":"Identification of GLA gene deletions in Fabry patients by multiplex ligation-dependent probe amplification (MLPA)","volume":"94","author":"Schirinzi","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1053\/j.ajkd.2023.03.015_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011;155(6):408]","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1053\/j.ajkd.2023.03.015_bib22","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/ndt\/gfq108","article-title":"The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease","volume":"25","author":"Rombach","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"2 suppl 1","key":"10.1053\/j.ajkd.2023.03.015_bib23","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2023.03.015_bib24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41581-019-0213-9","article-title":"Strengths and limitations of estimated and measured GFR","volume":"15","author":"Levey","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193550","article-title":"Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation","volume":"13","author":"Lavalle","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjophthalmol-2014-306433","article-title":"Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review","volume":"100","author":"Van der Tol","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1053\/j.ajkd.2023.03.015_bib27","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028830","article-title":"Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-\u03b2 and carbamazepine: a case report","volume":"101","author":"Kanai","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1053\/j.ajkd.2023.03.015_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2018.04.004","article-title":"Therapeutic goals in Fabry disease: recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy","volume":"126","author":"Wanner","year":"2019","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.kint.2016.10.004","article-title":"Screening, diagnosis, and management of patients with Fabry disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Schiffmann","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-021-00903-z","article-title":"Stepwise ABC system for classification of any type of genetic variant","volume":"30","author":"Houge","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib32","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.03.015_bib33","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2023.03.015_bib34","first-page":"53","article-title":"Early cardiac changes in children with Anderson-Fabry disease","volume":"11","author":"Havranek","year":"2013","journal-title":"JIMD Rep"},{"issue":"12","key":"10.1053\/j.ajkd.2023.03.015_bib35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/heartjnl-2014-306782","article-title":"Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry Disease","volume":"101","author":"Patel","year":"2015","journal-title":"Heart"},{"issue":"4","key":"10.1053\/j.ajkd.2023.03.015_bib36","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mgg3.389","article-title":"Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: a multicenter Fabry Registry study","volume":"6","author":"Germain","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"10.1053\/j.ajkd.2023.03.015_bib37","series-title":"Diagnostic Pathology: Kidney Diseases","first-page":"418","author":"Lindberg","year":"2016"},{"key":"10.1053\/j.ajkd.2023.03.015_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1750-1172-9-96","article-title":"Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4\u00a0+ 919G > A)","volume":"9","author":"Hsu","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2023.03.015_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium","volume":"324","author":"Von Scheidt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry\u2019s disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2023.03.015_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF03402156","article-title":"Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes","volume":"8","author":"Germain","year":"2002","journal-title":"Mol Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1053\/j.ajkd.2023.03.015_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017098","article-title":"Fabry disease due to D313Y and novel GLA mutations","volume":"7","author":"Koulousios","year":"2017","journal-title":"BMJ Open"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12883-019-1348-9","article-title":"Central nervous system vasculopathy caused by Fabry disease: a case report","volume":"19","author":"Kong","year":"2019","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12883-017-0810-9","article-title":"A\u00a0comparison of central nervous system involvement in patients with classical Fabry disease or the later-onset subtype with the IVS4+919G>A mutation","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Neurol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.03.015_bib46","first-page":"2596","article-title":"Mechanisms of mitochondrial dysfunction in lysosomal storage disorders: a review","volume":"9","author":"Stepien","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1053\/j.ajkd.2023.03.015_bib47","series-title":"Ultrastructural Pathology of the Cell and Matrix: A Text and Atlas of Physiological and Pathological Alterations in the Fine Structure of Cellular and Extracellular Components","first-page":"22","author":"Ghadially","year":"1988"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1053\/j.ajkd.2023.03.015_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/ene.13775","article-title":"Genomic screening of Fabry disease in young stroke patients: the Taiwan experience and a review of the literature","volume":"26","author":"Chang","year":"2019","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.03.015_bib50","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3174\/ajnr.A4677","article-title":"Brain MR imaging findings of cardiac-type Fabry disease with an IVS4+919G>A mutation","volume":"37","author":"Lee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ymgme.2014.08.007","article-title":"Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis","volume":"114","author":"Van der Tol","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2023.03.015_bib52","first-page":"247","article-title":"Light- and electron-microscopic histochemistry of Fabry\u2019s disease","volume":"103","author":"Faraggiana","year":"1981","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.03.015_bib53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.ki.5002414","article-title":"Peritubular endothelium: the Achilles heel of the kidney?","volume":"72","author":"Rabelink","year":"2007","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2023.03.015_bib54","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/15548627.2020.1713641","article-title":"Endothelial autophagy deficiency induces IL6-dependent endothelial mesenchymal transition and organ fibrosis","volume":"16","author":"Takagaki","year":"2020","journal-title":"Autophagy"},{"issue":"1","key":"10.1053\/j.ajkd.2023.03.015_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00441-017-2609-9","article-title":"Pathomechanisms of renal Fabry disease","volume":"369","author":"Eikrem","year":"2017","journal-title":"Cell Tissue Res"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623006558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623006558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:49:38Z","timestamp":1759463378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623006558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0272638623006558"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.03.015","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabry Disease Nephropathy: Histological Changes With Nonclassical Mutations and Genetic Variants of Unknown Significance","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}